Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx
| Image |  |
|---|---|
| Description | scientific article published on 01 February 2019 |
| Author/s |
author: Ilya Tsimafeyeu Sergey Gamayunov |
| Publication date | February 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |